Healthcare Professionals

Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications. Fresenius Medical Care supports nephrologists worldwide in minimizing their patients’ risks for cardiovascular morbidity and mortality.

HighVolumeHDF therapy as well as innovative membranes like Helixoneplus and modern monitoring features like the Blood Volume Monitor, together with ultrapure dialysis fluid, help minimize CVD risk factors and significantly improve the quality and efficacy of hemodialysis therapy.

Dialysis largely replicates the functions of the kidneys in patients with chronic kidney failure. Hemodialysis and peritoneal dialysis take over the key tasks of the kidneys, removing waste materials, toxins, excess salt and fluids from the body.

Dialysis treatment does not entirely replace all the functions of the kidneys, meaning that patients almost always need to take certain medications regularly. These include antihypertensive treatments, drugs for lowering phosphate levels in the blood, vitamins and drugs that boost the production of red blood cells to prevent anemia.

Fresenius Kidney Care, the dialysis care services division of Fresenius Medical Care, is striving to set the standard in the healthcare industry by delivering care that demonstrates improvements in the quality of life for every patient every day. We are known for our ability to successfully partner and work with physicians across the region. Our clinical care standards, safety procedures and advanced clinical research give physicians the reassurance that their patients are in caring and competent hands. With our performance management systems, we strive to improve patients’ medical outcomes while optimizing operational performances of clinics, taking all dimensions of patient care into account.

Fresenius Medical Care is highly committed to supporting the advancement of genuine medical/scientific education of healthcare professionals in relevant therapeutic areas, and therefore contributes to the improvement of healthcare standards and enhanced patient care.

• Education and services to support your therapy programme
• Selected congresses, meetings, seminars and symposia.
• Supporting medical and scientific education of healthcare professionals.
• Fresenius Medical Care Ventures was established to invest in start-ups and early-stage companies in the healthcare sector.